Last quarter (Q3 2024), NuGen Medical Devices Inc's total revenue was $531.82K, an increase of 359.18% from the same quarter last year. In Q3, NuGen Medical Devices Inc's net income was $-2.96M. See NuGen Medical Devices Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 762.79K	$ 331.40K	$ 152.36K	$ 137.65K	$ 47.30K
Cost of Revenue	$ 404.17K	$ 166.56K	$ 53.19K	$ 45.42K	$ 12.91K
Gross Profit	$ 358.63K	$ 164.84K	$ 99.17K	$ 92.22K	$ 34.38K
Operating Expense	$ 6.84M	$ 8.21M	$ 4.89M	$ 7.76M	$ 2.65M
Operating Income	$ -6.49M	$ -8.05M	$ -4.79M	$ -7.67M	$ -2.61M
Net Non Operating Interest Income Expense	$ -1.93M	$ -1.33M	$ -743.16K	$ 1.20M	$ 887.34K
Other Income Expense	$ -16.30K	$ -53.21K	$ -57.00K	$ 1.76M	$ -159.71K
Pretax Income	$ -8.27M	$ -9.33M	$ -5.57M	$ -7.10M	$ -3.66M
Tax Provision	$ 36.18K	$ 33.80K	$ 3.18K	$ 2.96K	$ 12.17K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -8.31M	$ -9.36M	$ -5.58M	$ -7.11M	$ -3.67M
Basic EPS	$ -0.03	$ -0.05	$ -0.06	$ -0.10	$ -0.04
Diluted EPS	$ -0.03	$ -0.05	$ -0.06	$ -0.10	$ -0.04
Basic Average Shares	$ 837.99M	$ 167.66M	$ 90.10M	$ 68.67M	$ 86.01M
Diluted Average Shares	$ 837.99M	$ 167.66M	$ 90.10M	$ 68.67M	$ 86.01M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 3.90M	$ ―	$ 4.94M	$ -7.81M	$ -2.66M
Net Income From Continuing And Discontinued Operation	$ -8.31M	$ -9.36M	$ -5.58M	$ -7.11M	$ -3.67M
Normalized Income	$ -7.54M	$ -6.86M	$ -4.10M	$ -6.10M	$ -2.69M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -6.27M	$ -7.98M	$ -5.55M	$ -5.88M	$ -2.99M
EBITDA	$ -5.79M	$ -7.29M	$ -4.90M	$ -5.09M	$ -2.59M

Currency in USD

NuGen Medical Devices Inc Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing